Article
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Antiviral therapy - 1 Jun 2003
Delaugerre Constance, Gourlain Karine, Tubiana Roland, Carcelain Guislaine, Marcelin Anne-Geneviève, Chouquet Cécile, Mouroux Mireille, Duvivier Claudine, Autran Brigitte, Costagliola Dominique, Katlama Christine, Calvez Vincent
Abstract excerpt
OBJECTIVE: To assess the effect of interleukin (IL)-2 combined with highly active antiretroviral therapy (HAART) on HIV-1 pro-viral DNA quantification in HIV-1-infected patients with CD4<200/mm3. PATIENTS AND METHODS: Seventy patients with CD4<200 cells/mm3 and CV<1000 copies/ml were enrolled in a 6-month randomized controlled study to evaluate the subcutaneous injection of IL-2 in addition to HAART versus HAART...
Topics
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- DNA, Viral
- Drug Resistance, Viral
- Drug Therapy, Combination
- Female
- HIV Infections
